Clinical research demonstrates that oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function
This is why most patients are advised to schedule follow-up treatments every three months to maintain continuous relief
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
Nausea is typically worst in the first few days following a dose increase
Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis